BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1329363)

  • 1. Hep G2 cell line as a human model for sulphate conjugation of drugs.
    Shwed JA; Walle UK; Walle T
    Xenobiotica; 1992 Aug; 22(8):973-82. PubMed ID: 1329363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.
    Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S
    Chirality; 2001; 13(3):140-7. PubMed ID: 11270323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective sulphate conjugation of fenoterol by human phenolsulphotransferases.
    Wilson AA; Wang J; Koch P; Walle T
    Xenobiotica; 1997 Nov; 27(11):1147-54. PubMed ID: 9413918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol.
    Walle T; Walle UK
    Br J Clin Pharmacol; 1990 Jul; 30(1):127-33. PubMed ID: 2390423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of propranolol metabolism in the Hep G2 human hepatoma cell line.
    Steiner A; Walle UK; Walle T
    J Pharm Pharmacol; 1992 Jul; 44(7):611-4. PubMed ID: 1357146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary modulation of human platelet phenolsulphotransferase activity.
    Harris RM; Waring RH
    Xenobiotica; 1996 Dec; 26(12):1241-7. PubMed ID: 9004454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol.
    Walle T; Walle UK
    Drug Metab Dispos; 1991; 19(2):448-53. PubMed ID: 1676652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells.
    Galijatovic A; Otake Y; Walle UK; Walle T
    Xenobiotica; 1999 Dec; 29(12):1241-56. PubMed ID: 10647910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferases.
    Christ DD; Walle T
    J Pharmacol Exp Ther; 1989 Dec; 251(3):949-55. PubMed ID: 2600823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.
    Walle UK; Pesola GR; Walle T
    Br J Clin Pharmacol; 1993 Apr; 35(4):413-8. PubMed ID: 8485021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenolsulfotransferases.
    Walle T; Walle UK
    Drug Metab Dispos; 1992; 20(2):333-6. PubMed ID: 1352231
    [No Abstract]   [Full Text] [Related]  

  • 12. Human phenol sulfotransferases: chiral substrates and expression in Hep G2 cells.
    Walle T; Walle UK; Shwed JA; Thornburg KR; Mathis CE; Pesola GR
    Chem Biol Interact; 1994 Jun; 92(1-3):47-55. PubMed ID: 7913418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.
    Veronese ME; Burgess W; Zhu X; McManus ME
    Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):497-502. PubMed ID: 8093002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention.
    Eaton EA; Walle UK; Lewis AJ; Hudson T; Wilson AA; Walle T
    Drug Metab Dispos; 1996 Feb; 24(2):232-7. PubMed ID: 8742236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymic sulphation of dopa and tyrosine isomers by HepG2 human hepatoma cells: stereoselectivity and stimulation by Mn2+.
    Suiko M; Sakakibara Y; Nakajima H; Sakaida H; Liu MC
    Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):151-8. PubMed ID: 8660277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.
    Jones AL; Roberts RC; Colvin DW; Rubin GL; Coughtrie MW
    Eur J Clin Pharmacol; 1995; 49(1-2):109-14. PubMed ID: 8751031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase.
    Seah VM; Wong KP
    Biochem Pharmacol; 1994 May; 47(10):1743-9. PubMed ID: 8204091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.
    Sundaram RS; Szumlanski C; Otterness D; van Loon JA; Weinshilboum RM
    Drug Metab Dispos; 1989; 17(3):255-64. PubMed ID: 2568905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cirrhosis on sulphation by the isolated perfused rat liver.
    Choo EF; Angus PW; Morgan DJ
    J Hepatol; 1999 Mar; 30(3):498-502. PubMed ID: 10190735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol.
    Rein G; Glover V; Sandler M
    Biochem Pharmacol; 1982 May; 31(10):1893-7. PubMed ID: 6954952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.